You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

c-Met inhibitor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tumors Trial (ABN401)

Not yet recruiting
  • Neoplasms
  • (no location specified)
May 21, 2023

Solid Tumor Trial in Bengbu (SPH 3348)

Recruiting
  • Solid Tumor
  • SPH 3348
  • Bengbu, Anhui, China
    The First Affliated Hospital of Bengbu Medical College
Jul 25, 2022

Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial (procedure, biological, drug)

Not yet recruiting
  • Recurrent Lung Non-Small Cell Carcinoma
  • Stage IV Lung Cancer AJCC v8
  • Biospecimen Collection
  • +5 more
  • (no location specified)
Sep 7, 2023

Colorectal Cancer Metastatic, C-met Overexpression Trial in Rozzano (Tivantinib (ARQ197))

Completed
  • Colorectal Cancer Metastatic
  • C-met Overexpression
  • Tivantinib (ARQ197)
  • Rozzano, Milano, Italy
    Istituto Clinico Humanitas
Sep 8, 2022

Patients With Solid Tumors, Either Refractory to Standard Therapy or for Which no Effective Standard Therapy is Available Trial

Completed
Has Results
  • Patients With Solid Tumors, Either Refractory to Standard Therapy or for Which no Effective Standard Therapy is Available
  • Houston, Texas
    M.D. Anderson Cancer Center
Aug 22, 2022

Tumor, Solid Tumors Trial in Camperdown, Liverpool (HS-10241)

Completed
  • Neoplasm
  • Solid Tumors
  • Camperdown, New South Wales, Australia
  • +1 more
Jul 18, 2022

Hepatic Impairment Trial in Miami, Orlando (Tepotinib)

Completed
  • Hepatic Impairment
  • Miami, Florida
  • +1 more
Aug 22, 2022

Solid Tumors Trial in Kashiwa, Shizuoka (MSC2156119J)

Completed
Has Results
  • Solid Tumors
  • Kashiwa, Japan
  • +1 more
Jul 23, 2020

NSCLC ALK-positive, NSCLC c-Met Dependent, NSCLC ROS Marker Positive Trial in Worldwide (PF-02341066, Rifampin, Itraconazole)

Completed
Has Results
  • Non-Small Cell Lung Cancer ALK-positive
  • +4 more
  • Orange, California
  • +28 more
Feb 15, 2022

Malignant Non-small Cell Tumor of Lung Stage IV Trial in Boston (Capmatinib (INC280))

Completed
Has Results
  • Malignant Non-small Cell Neoplasm of Lung Stage IV
  • Capmatinib (INC280)
  • Boston, Massachusetts
    Massachusetts General Hospital
Mar 11, 2022

Solid Tumor, Colorectal Cancer Trial in Oxford (PF-02341066, PD-0325901, Binimetinib)

Completed
Has Results
  • Solid Tumor
  • Colorectal Cancer
  • Oxford, United Kingdom
    Oxford University Hospital NHS Trust
Jun 14, 2021

Solid Tumor, C-Met Mutation-Related Tumors Trial in Shanghai (GST-HG161)

Unknown status
  • Solid Tumor
  • C-Met Mutation-Related Tumors
  • Shanghai, Shanghai, China
    Shanghai Oriental Hospital
Jan 10, 2020

NSCLC Trial (Telisotuzumab Vedotin, Osimertinib, Cisplatin)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Telisotuzumab Vedotin
  • +4 more
  • (no location specified)
Oct 17, 2023

Advanced Solid Tumors Trial in Goyang-si, Seoul (ABN401)

Not yet recruiting
  • Advanced Solid Tumors
  • Goyang-si, Gyeonggi-Do, Korea, Republic of
  • +2 more
Sep 13, 2022

Novel FLUorescENt C-mEt Tracer in Penile and Tongue

Completed
  • Head and Neck Cancer
  • Penile Cancer
    • Amsterdam, Noord-Holland, Netherlands
      The Netherlands Cancer Institute / Antoni van Leeuwenhoek
    Oct 18, 2022

    Kidney Cancer Trial run by the NCI (INC280)

    Completed
    • Kidney Cancer
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Dec 18, 2021

    Glioma Trial in Beijing (PLB1001)

    Completed
    • Glioma
    • Beijing, Beijing, China
      Beijing Shijitan Hospital,CMU
    Mar 2, 2020

    Carcinoma, Hepatocellular Trial in Darmstadt (Tepotinib)

    Completed
    Has Results
    • Carcinoma, Hepatocellular
    • Darmstadt, Germany
      Please contact the Merck KGaA Communication Center located in
    Aug 22, 2022

    Solid Tumor Trial in United States (TR1801-ADC)

    Active, not recruiting
    • Unspecified Adult Solid Tumor, Protocol Specific
    • TR1801-ADC
    • Los Angeles, California
    • +4 more
    Oct 30, 2022

    Lung Non-Small Cell Carcinoma Trial (Amivantamab, Biospecimen Collection, Computed Tomography)

    Not yet recruiting
    • Lung Non-Small Cell Carcinoma
    • Amivantamab
    • +3 more
    • (no location specified)
    Oct 30, 2023

    Endometrial Cancer Recurrent Trial in Tainan (Crizotinib 250 MG)

    Recruiting
    • Endometrial Cancer Recurrent
    • Crizotinib 250 MG
    • Tainan, Taiwan
      National Cheng Kung University Hospital
    Jun 6, 2022

    NSCLC (NSCLC) Trial in China (Capmatinib)

    Recruiting
    • Non-Small Cell Lung Cancer (NSCLC)
    • Xiamen, Fujian, China
    • +18 more
    Jan 27, 2023

    Recurrent NSCLC Trial in Sacramento, San Francisco (INC280, erlotinib HCl)

    Completed
    • Recurrent Non-small Cell Lung Cancer
    • Sacramento, California
    • +1 more
    Oct 11, 2021

    Recurrent Squamous Cell Lung Carcinoma, Stage IV Squamous Cell Lung Carcinoma AJCC V7 Trial in Houston (ABBV-399)

    Completed
    Has Results
    • Recurrent Squamous Cell Lung Carcinoma
    • Stage IV Squamous Cell Lung Carcinoma AJCC V7
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 21, 2021

    Adult Solid Tumor, Advanced Solid Tumor, Refractory Tumor Trial in Bruxelles, Edegem, Rotterdam (DO-2)

    Recruiting
    • Adult Solid Tumor
    • +2 more
    • Bruxelles, Belgium
    • +2 more
    Mar 1, 2023